Home
Services
Portfolio
People
Jobs
Search
Services
Portfolio
People
Jobs
News
Recent News
COVIDRIVE welcomes three new vaccine companies to the consortium
9 February 2022
08/02/2022 – Three new vaccine companies (Moderna, Novavax and Valneva) have joined the COVIDRIVE consortium and officially become COVIDRIVE partners. Moderna, Novavax and Valneva will further contribute to the assessment of the effectiveness of COVID-19 vaccines in Europe to support the region’s public health response and address the vaccine companies’ regulatory obligations. With the inclusion of these three newcomers, COVIDRIVE, which brings together public institutions, small and medium-sized enterprises and vaccine companies, has a total of 11 partners….
Read more…
P95 nominated for the Trends Gazelles Flemish Brabant 2022
24 November 2021
P95 is one of the nominees for the 2022 edition of Trends Gazelles Flemish Brabant. Trends Gazelles award aims to distinguish the fastest-growing Belgian companies over the past 5 years….
Read more…
P95 appoints Henk Hoornaert as Chief Commercial Officer
16 November 2021
P95 has appointed Henk Hoornaert as Chief Commercial Officer (CCO). After two years of accelerated growth, this appointment will strengthen P95’s structure and improve business development, marking a further step towards a more stable and mature organization….
Read more…
Largest ever Lassa fever study expands to more countries in West Africa
28 July 2021
July 28 2021, Oslo Norway, Cotonou Benin, Conakry Guinea, Monrovia Liberia, Abuja Nigeria, and Kenema Sierra Leone – The largest ever study created and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to provide a more accurate assessment of the incidence of Lassa fever infections has launched in several more countries in West Africa….
Read more…
The COVIDRIVE project has been officially launched
22 July 2021
A new public-private partnership – COVIDRIVE – announced today that it will begin studies to assess the effectiveness of multiple […]…
Read more…
